OXULUMIS
Live / Allowed — Notice of allowance issued (as of 21 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99068812
- Mark type
- Stylized text
- Filed
- 05 Mar 2025
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Jeffrey J. Scepanski
Goods and services
- Class 005 — Pharmaceuticals: Combination drug delivery devices sold full containing pharmaceutical preparations for the treatment of retinal diseases
- Class 010 — Medical apparatus: Combination drug delivery devices sold empty for the treatment of retinal diseases
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jul 2025 — ASSIGNED TO EXAMINER
- 10 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 05 Mar 2025 — NEW APPLICATION ENTERED